The COX-2/PGE 2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
A Greenhough, HJM Smartt, AE Moore… - …, 2009 - academic.oup.com
It is widely accepted that alterations to cyclooxygenase-2 (COX-2) expression and the
abundance of its enzymatic product prostaglandin E 2 (PGE 2) have key roles in influencing …
abundance of its enzymatic product prostaglandin E 2 (PGE 2) have key roles in influencing …
Epigenetics of aging and aging-associated diseases
Aging represents the multifactorial decline in physiological function of every living organism.
Over the past decades, several hallmarks of aging have been defined, including epigenetic …
Over the past decades, several hallmarks of aging have been defined, including epigenetic …
The DNA methylation landscape of advanced prostate cancer
Although DNA methylation is a key regulator of gene expression, the comprehensive
methylation landscape of metastatic cancer has never been defined. Through whole …
methylation landscape of metastatic cancer has never been defined. Through whole …
DNA methylation profiling in the clinic: applications and challenges
Abstract Knowledge of epigenetic alterations in disease is rapidly increasing owing to the
development of genome-wide techniques for their identification. The ever-growing number …
development of genome-wide techniques for their identification. The ever-growing number …
Prostate cancer and inflammation: the evidence
Sfanos KS & De Marzo AM (2012) Histopathology 60, 199–215 Prostate cancer and
inflammation: the evidence Chronic inflammation is now known to contribute to several …
inflammation: the evidence Chronic inflammation is now known to contribute to several …
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
Loss of androgen receptor (AR) signaling dependence occurs in approximately 15%–20%
of advanced treatment-resistant prostate cancers, and this may manifest clinically as …
of advanced treatment-resistant prostate cancers, and this may manifest clinically as …
Inflammation and necrosis promote tumour growth
J Vakkila, MT Lotze - Nature Reviews Immunology, 2004 - nature.com
In children, cancer probably arises from a combination of inherited genetic mutations and
genetic alterations that are acquired during the rapid cellular expansion that occurs during …
genetic alterations that are acquired during the rapid cellular expansion that occurs during …
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Many studies have shown that primary prostate cancers are multifocal,, and are composed
of multiple genetically distinct cancer cell clones,,. Whether or not multiclonal primary …
of multiple genetically distinct cancer cell clones,,. Whether or not multiclonal primary …
Epigenetics in cancer therapy and nanomedicine
A Roberti, AF Valdes, R Torrecillas, MF Fraga… - Clinical …, 2019 - Springer
The emergence of nanotechnology applied to medicine has revolutionized the treatment of
human cancer. As in the case of classic drugs for the treatment of cancer, epigenetic drugs …
human cancer. As in the case of classic drugs for the treatment of cancer, epigenetic drugs …
[HTML][HTML] DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
Cancer is characterized by hypomethylation-associated silencing of large chromatin
domains, whose contribution to tumorigenesis is uncertain. Through high-resolution genome …
domains, whose contribution to tumorigenesis is uncertain. Through high-resolution genome …